Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 production

Oncotarget

Volumn 6, Issue 10, 2015, Pages 7713-7726

  Wei, Hong Jian ^a   Zeng, Rong ^b   Lu, Jui Hua ^a   Lai, Wen Fu T ^a   Chen, Wei Hong ^a   Liu, Hen Yu ^a   Chang, Ya Ting ^a   Deng, Win Ping ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Adipose derived stem cells; Breast cancer; Cancer stem cell; Colon cancer; Tumor initiation

Indexed keywords

INTERLEUKIN 6; JANUS KINASE 2; STAT3 PROTEIN;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; CELL INTERACTION; CELL ISOLATION; COCULTURE; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; ADIPOCYTE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CANCER STEM CELL; CELL PROLIFERATION; COLON TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ADIPOCYTES; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; HETEROGRAFTS; HUMANS; INTERLEUKIN-6; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS;

EID: 84928398990     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3481     Document Type: Article

References (48)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-147.
2. Friedenstein AJ, Chailakhjan RK and Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3(4):393-403.
3. Murray IR, West CC, Hardy WR, James AW, Park TS, Nguyen A, Tawonsawatruk T, Lazzari L, Soo C and Peault B. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci. 2014; 71(8):1353-1374.
4. Konno M, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Nishikawa S, Ohta K, Kano Y, Ozaki M, Noguchi Y, Sakai D, Kudoh T, Kawamoto K, Eguchi H, Satoh T, Tanemura M, et al. Adipose-derived mesenchymal stem cells and regenerative medicine. Dev Growth Differ. 2013; 55(3):309-318.
5. Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su TC, Lin RJ, Yang DM, Chang CW, Chen WH, Wei HJ and Gelovani JG. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res. 2005; 11(21):7749-7756.
6. Ahn J, Lee H, Seo K, Kang S, Ra J and Youn H. Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-beta and treatment with cisplatin in a xenograft mouse model for canine melanoma. PLoS One. 2013; 8(9):e74897.
7. Sun Z, Wang S and Zhao RC. The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol. 2014; 7:14.
8. Rezaeifard S, Razmkhah M, Robati M, Momtahan M and Ghaderi A. Adipose derived stem cells isolated from omentum: a novel source of chemokines for ovarian cancer growth. J Cancer Res Ther. 2014; 10(1):159-164.
9. Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB and Alt EU. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis. 2009; 30(4):589-597.
10. Ji SQ, Cao J, Zhang QY, Li YY, Yan YQ and Yu FX. Adipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion. Braz J Med Biol Res. 2013; 46(9):758-764.
11. Heo SC, Lee KO, Shin SH, Kwon YW, Kim YM, Lee CH, Kim YD, Lee MK, Yoon MS and Kim JH. Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth in a xenograft lung adenocarcinoma model. Biochim Biophys Acta. 2011; 1813(12):2061-2070.
12. Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian C, Li J, Yan X, Liu Y, Shao C and Zhao RC. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia. 2009; 23(5):925-933.
13. Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, Touil I, Andre M, Grolleau JL, Peron JM, Chavoin JP, Bourin P, Penicaud L, Casteilla L, Buscail L and Cordelier P. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One. 2009; 4(7):e6278.
14. Sun B, Roh KH, Park JR, Lee SR, Park SB, Jung JW, Kang SK, Lee YS and Kang KS. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy. 2009; 11(3):289-298, 281 p following 298.
15. Wolin KY, Carson K and Colditz GA. Obesity and cancer. Oncologist. 2010; 15(6):556-565.
16. Zhang Y, Daquinag AC, Amaya-Manzanares F, Sirin O, Tseng C and Kolonin MG. Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Res. 2012; 72(20):5198-5208.
17. Daquinag AC, Zhang Y and Kolonin MG. Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol Sci. 2011; 32(5):300-307.
18. Strong AL, Strong TA, Rhodes LV, Semon JA, Zhang X, Shi Z, Zhang S, Gimble JM, Burow ME and Bunnell BA. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Res. 2013; 15(5):R102.
19. Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D and Klopp AH. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One. 2013; 8(12):e81859.
20. Yu JM, Jun ES, Bae YC and Jung JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008; 17(3):463-473.
21. Eterno V, Zambelli A, Pavesi L, Villani L, Zanini V, Petrolo G, Manera S, Tuscano A and Amato A. Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling. Oncotarget. 2014; 5(3):613-633.
22. Rowan BG, Gimble JM, Sheng M, Anbalagan M, Jones RK, Frazier TP, Asher M, Lacayo EA, Friedlander PL, Kutner R and Chiu ES. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS One. 2014; 9(2):e89595.
23. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F. (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. IARC CancerBase No 11 [Internet]. (Lyon, France: International Agency for Research on Cancer).
24. Ligibel JA and Strickler HD. Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educ Book. 2013:52-59.
25. Bardou M, Barkun AN and Martel M. Obesity and colorectal cancer. Gut. 2013; 62(6):933-947.
26. Pastrana E, Silva-Vargas V and Doetsch F. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. 2011; 8(5):486-498.
27. Guo Y, Xu F, Lu T, Duan Z and Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012; 38(7):904-910.
28. Hsu HS, Lin JH, Hsu TW, Su K, Wang CW, Yang KY, Chiou SH and Hung SC. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Lung Cancer. 2012; 75(2):167-177.
29. Tsai KS, Yang SH, Lei YP, Tsai CC, Chen HW, Hsu CY, Chen LL, Wang HW, Miller SA, Chiou SH, Hung MC and Hung SC. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology. 2011; 141(3):1046-1056.
30. Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R and Wicha MS. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 2011; 71(2):614-624.
31. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D and Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-317.
32. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D and Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 2007; 21(2):304-310.
33. Bergfeld SA and DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010; 29(2):249-261.
34. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ and Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010; 16(6):1884-1893.
35. Dignam JJ and Mamounas EP. Obesity and breast cancer prognosis: an expanding body of evidence. Ann Oncol. 2004; 15(6):850-851.
36. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A and Berger NA. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila). 2012; 5(11):1260-1272.
37. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L and Karin M. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009; 15(2):103-113.
38. Dethlefsen C, Hojfeldt G and Hojman P. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat. 2013; 138(3):657-664.
39. Rokavec M, Oner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR and Hermeking H. IL-6R/STAT3/miR-34a feedback loop promotes EMTmediated colorectal cancer invasion and metastasis. J Clin Invest. 2014; 124(4):1853-1867.
40. Yadav A, Kumar B, Datta J, Teknos TN and Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAKSTAT3-SNAIL signaling pathway. Mol Cancer Res. 2011; 9(12):1658-1667.
41. Liu Y, Li PK, Li C and Lin J. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells. J Biol Chem. 2010; 285(35):27429-27439.
42. Hodge DR, Hurt EM and Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005; 41(16):2502-2512.
43. Heikkila K, Ebrahim S and Lawlor DA. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer. 2008; 44(7):937-945.
44. Eder K, Baffy N, Falus A and Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009; 58(11):727-736.
45. Kimbrel EA, Davis TN, Bradner JE and Kung AL. In vivo pharmacodynamic imaging of proteasome inhibition. Mol Imaging. 2009; 8(3):140-147.
46. Liu HY, Chiou JF, Wu AT, Tsai CY, Leu JD, Ting LL, Wang MF, Chen HY, Lin CT, Williams DF and Deng WP. The effect of diminished osteogenic signals on reduced osteoporosis recovery in aged mice and the potential therapeutic use of adipose-derived stem cells. Biomaterials. 2012; 33(26):6105-6112.
47. Wei HJ, Wu AT, Hsu CH, Lin YP, Cheng WF, Su CH, Chiu WT, Whang-Peng J, Douglas FL and Deng WP. The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine. Mol Ther. 2011; 19(12):2249-2257.
48. Chen WH, Zeng R, Lo WC, Tina Chen SY, Lai TY, Williams DF and Deng WP. The role of the ERK1/2 pathway as an alternative to the aging-diminished cyclic AMP pathway in calcitonin-mediated chondrogenesis in human nucleus pulposus. Biomaterials. 2012; 33(33):8256-8264.